Covid-19 Impact on Branded Generics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Branded Generics, including the following market information:
Major competitors identified in this market include Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health, etc.
Based on the Region:
- Global Branded Generics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Branded Generics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Branded Generics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Branded Generics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Major competitors identified in this market include Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Oral
- Parenteral
- Topical
- Other
- Oncology
- Cardiovascular Diseases
- Diabetes
- Neurology
- Gastrointestinal Diseases
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Branded Generics Industry
1.7 COVID-19 Impact: Branded Generics Market Trends
2 GLOBAL BRANDED GENERICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Branded Generics Business Impact Assessment - COVID-19
2.1.1 Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Branded Generics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Branded Generics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Branded Generics Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Branded Generics Factory Price by Manufacturers
3.3 Location of Key Manufacturers Branded Generics Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Branded Generics Market
3.5 Key Manufacturers Branded Generics Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BRANDED GENERICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Oral
1.4.2 Parenteral
1.4.3 Topical
1.4.4 Other
4.2 By Type, Global Branded Generics Market Size, 2019-2021
4.2.1 By Type, Global Branded Generics Market Size by Type, 2020-2021
4.2.2 By Type, Global Branded Generics Price, 2020-2021
5 IMPACT OF COVID-19 ON BRANDED GENERICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Cardiovascular Diseases
5.5.3 Diabetes
5.5.4 Neurology
5.5.5 Gastrointestinal Diseases
5.2 By Application, Global Branded Generics Market Size, 2019-2021
5.2.1 By Application, Global Branded Generics Market Size by Application, 2019-2021
5.2.2 By Application, Global Branded Generics Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Mylan NV
7.1.1 Mylan NV Business Overview
7.1.2 Mylan NV Branded Generics Quarterly Production and Revenue, 2020
7.1.3 Mylan NV Branded Generics Product Introduction
7.1.4 Mylan NV Response to COVID-19 and Related Developments
7.2 Novartis AG
7.2.1 Novartis AG Business Overview
7.2.2 Novartis AG Branded Generics Quarterly Production and Revenue, 2020
7.2.3 Novartis AG Branded Generics Product Introduction
7.2.4 Novartis AG Response to COVID-19 and Related Developments
7.3 Eva Pharmaceutical Industries
7.3.1 Eva Pharmaceutical Industries Business Overview
7.3.2 Eva Pharmaceutical Industries Branded Generics Quarterly Production and Revenue, 2020
7.3.3 Eva Pharmaceutical Industries Branded Generics Product Introduction
7.3.4 Eva Pharmaceutical Industries Response to COVID-19 and Related Developments
7.4 Pfizer
7.4.1 Pfizer Business Overview
7.4.2 Pfizer Branded Generics Quarterly Production and Revenue, 2020
7.4.3 Pfizer Branded Generics Product Introduction
7.4.4 Pfizer Response to COVID-19 and Related Developments
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Business Overview
7.5.2 Sun Pharmaceutical Industries Branded Generics Quarterly Production and Revenue, 2020
7.5.3 Sun Pharmaceutical Industries Branded Generics Product Introduction
7.5.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
7.6 Aspen Pharmacare Holding
7.6.1 Aspen Pharmacare Holding Business Overview
7.6.2 Aspen Pharmacare Holding Branded Generics Quarterly Production and Revenue, 2020
7.6.3 Aspen Pharmacare Holding Branded Generics Product Introduction
7.6.4 Aspen Pharmacare Holding Response to COVID-19 and Related Developments
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Business Overview
7.7.2 Abbott Laboratories Branded Generics Quarterly Production and Revenue, 2020
7.7.3 Abbott Laboratories Branded Generics Product Introduction
7.7.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.8 Bausch Health
7.8.1 Bausch Health Business Overview
7.8.2 Bausch Health Branded Generics Quarterly Production and Revenue, 2020
7.8.3 Bausch Health Branded Generics Product Introduction
7.8.4 Bausch Health Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Branded Generics Supply Chain Analysis
8.1.1 Branded Generics Supply Chain Analysis
8.1.2 Covid-19 Impact on Branded Generics Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Branded Generics Distribution Channels
8.2.2 Covid-19 Impact on Branded Generics Distribution Channels
8.2.3 Branded Generics Distributors
8.3 Branded Generics Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Branded Generics Industry
1.7 COVID-19 Impact: Branded Generics Market Trends
2 GLOBAL BRANDED GENERICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Branded Generics Business Impact Assessment - COVID-19
2.1.1 Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Branded Generics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Branded Generics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Branded Generics Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Branded Generics Factory Price by Manufacturers
3.3 Location of Key Manufacturers Branded Generics Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Branded Generics Market
3.5 Key Manufacturers Branded Generics Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BRANDED GENERICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Oral
1.4.2 Parenteral
1.4.3 Topical
1.4.4 Other
4.2 By Type, Global Branded Generics Market Size, 2019-2021
4.2.1 By Type, Global Branded Generics Market Size by Type, 2020-2021
4.2.2 By Type, Global Branded Generics Price, 2020-2021
5 IMPACT OF COVID-19 ON BRANDED GENERICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Cardiovascular Diseases
5.5.3 Diabetes
5.5.4 Neurology
5.5.5 Gastrointestinal Diseases
5.2 By Application, Global Branded Generics Market Size, 2019-2021
5.2.1 By Application, Global Branded Generics Market Size by Application, 2019-2021
5.2.2 By Application, Global Branded Generics Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Mylan NV
7.1.1 Mylan NV Business Overview
7.1.2 Mylan NV Branded Generics Quarterly Production and Revenue, 2020
7.1.3 Mylan NV Branded Generics Product Introduction
7.1.4 Mylan NV Response to COVID-19 and Related Developments
7.2 Novartis AG
7.2.1 Novartis AG Business Overview
7.2.2 Novartis AG Branded Generics Quarterly Production and Revenue, 2020
7.2.3 Novartis AG Branded Generics Product Introduction
7.2.4 Novartis AG Response to COVID-19 and Related Developments
7.3 Eva Pharmaceutical Industries
7.3.1 Eva Pharmaceutical Industries Business Overview
7.3.2 Eva Pharmaceutical Industries Branded Generics Quarterly Production and Revenue, 2020
7.3.3 Eva Pharmaceutical Industries Branded Generics Product Introduction
7.3.4 Eva Pharmaceutical Industries Response to COVID-19 and Related Developments
7.4 Pfizer
7.4.1 Pfizer Business Overview
7.4.2 Pfizer Branded Generics Quarterly Production and Revenue, 2020
7.4.3 Pfizer Branded Generics Product Introduction
7.4.4 Pfizer Response to COVID-19 and Related Developments
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Business Overview
7.5.2 Sun Pharmaceutical Industries Branded Generics Quarterly Production and Revenue, 2020
7.5.3 Sun Pharmaceutical Industries Branded Generics Product Introduction
7.5.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
7.6 Aspen Pharmacare Holding
7.6.1 Aspen Pharmacare Holding Business Overview
7.6.2 Aspen Pharmacare Holding Branded Generics Quarterly Production and Revenue, 2020
7.6.3 Aspen Pharmacare Holding Branded Generics Product Introduction
7.6.4 Aspen Pharmacare Holding Response to COVID-19 and Related Developments
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Business Overview
7.7.2 Abbott Laboratories Branded Generics Quarterly Production and Revenue, 2020
7.7.3 Abbott Laboratories Branded Generics Product Introduction
7.7.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.8 Bausch Health
7.8.1 Bausch Health Business Overview
7.8.2 Bausch Health Branded Generics Quarterly Production and Revenue, 2020
7.8.3 Bausch Health Branded Generics Product Introduction
7.8.4 Bausch Health Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Branded Generics Supply Chain Analysis
8.1.1 Branded Generics Supply Chain Analysis
8.1.2 Covid-19 Impact on Branded Generics Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Branded Generics Distribution Channels
8.2.2 Covid-19 Impact on Branded Generics Distribution Channels
8.2.3 Branded Generics Distributors
8.3 Branded Generics Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Branded Generics Assessment
Table 9. COVID-19 Impact: Branded Generics Market Trends
Table 10. COVID-19 Impact Global Branded Generics Market Size
Table 11. Global Branded Generics Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Branded Generics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Branded Generics Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Branded Generics Market Growth Drivers
Table 17. Global Branded Generics Market Restraints
Table 18. Global Branded Generics Market Opportunities
Table 19. Global Branded Generics Market Challenges
Table 20. Key Manufacturers Branded Generics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Branded Generics Market Size, 2019 (K MT) & (US$ Million)
Table 22. Branded Generics Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Branded Generics Manufacturing Plants
Table 24. Key Manufacturers Branded Generics Market Served
Table 25. Date of Key Manufacturers Enter into Branded Generics Market
Table 26. Key Manufacturers Branded Generics Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Branded Generics Market Size by Type, 2020, (US$ Million)
Table 29. Global Branded Generics Market Size by Type, 2020 (K MT)
Table 30. Global Branded Generics Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Branded Generics Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Branded Generics Market Size by Application, 2020-2021 (K MT)
Table 33. Global Branded Generics Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Branded Generics Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Branded Generics Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Branded Generics Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Branded Generics Market Size, 2019-2021 (K MT)
Table 38. US Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Branded Generics Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Branded Generics Market Size, 2019-2021 (K MT)
Table 43. Germany Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Branded Generics Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Branded Generics Market Size, 2019-2021 (K MT)
Table 50. China Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Mylan NV Business Overview
Table 58. Mylan NV Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Mylan NV Branded Generics Product
Table 60. Mylan NV Response to COVID-19 and Related Developments
Table 61. Novartis AG Business Overview
Table 62. Novartis AG Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis AG Branded Generics Product
Table 64. Novartis AG Response to COVID-19 and Related Developments
Table 65. Eva Pharmaceutical Industries Business Overview
Table 66. Eva Pharmaceutical Industries Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eva Pharmaceutical Industries Branded Generics Product
Table 68. Eva Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 69. Pfizer Business Overview
Table 70. Pfizer Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Pfizer Branded Generics Product
Table 72. Pfizer Response to COVID-19 and Related Developments
Table 73. Sun Pharmaceutical Industries Business Overview
Table 74. Sun Pharmaceutical Industries Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Sun Pharmaceutical Industries Branded Generics Product
Table 76. Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 77. Aspen Pharmacare Holding Business Overview
Table 78. Aspen Pharmacare Holding Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Aspen Pharmacare Holding Branded Generics Product
Table 80. Aspen Pharmacare Holding Response to COVID-19 and Related Developments
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Abbott Laboratories Branded Generics Product
Table 84. Abbott Laboratories Response to COVID-19 and Related Developments
Table 85. Bausch Health Business Overview
Table 86. Bausch Health Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bausch Health Branded Generics Product
Table 88. Bausch Health Response to COVID-19 and Related Developments
Table 89. Branded Generics Distributors List
Table 90. Branded Generics Customers List
Table 91. Covid-19 Impact on Branded Generics Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Branded Generics Assessment
Table 9. COVID-19 Impact: Branded Generics Market Trends
Table 10. COVID-19 Impact Global Branded Generics Market Size
Table 11. Global Branded Generics Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Branded Generics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Branded Generics Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Branded Generics Market Growth Drivers
Table 17. Global Branded Generics Market Restraints
Table 18. Global Branded Generics Market Opportunities
Table 19. Global Branded Generics Market Challenges
Table 20. Key Manufacturers Branded Generics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Branded Generics Market Size, 2019 (K MT) & (US$ Million)
Table 22. Branded Generics Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Branded Generics Manufacturing Plants
Table 24. Key Manufacturers Branded Generics Market Served
Table 25. Date of Key Manufacturers Enter into Branded Generics Market
Table 26. Key Manufacturers Branded Generics Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Branded Generics Market Size by Type, 2020, (US$ Million)
Table 29. Global Branded Generics Market Size by Type, 2020 (K MT)
Table 30. Global Branded Generics Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Branded Generics Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Branded Generics Market Size by Application, 2020-2021 (K MT)
Table 33. Global Branded Generics Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Branded Generics Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Branded Generics Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Branded Generics Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Branded Generics Market Size, 2019-2021 (K MT)
Table 38. US Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Branded Generics Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Branded Generics Market Size, 2019-2021 (K MT)
Table 43. Germany Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Branded Generics Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Branded Generics Market Size, 2019-2021 (K MT)
Table 50. China Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Branded Generics Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Mylan NV Business Overview
Table 58. Mylan NV Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Mylan NV Branded Generics Product
Table 60. Mylan NV Response to COVID-19 and Related Developments
Table 61. Novartis AG Business Overview
Table 62. Novartis AG Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis AG Branded Generics Product
Table 64. Novartis AG Response to COVID-19 and Related Developments
Table 65. Eva Pharmaceutical Industries Business Overview
Table 66. Eva Pharmaceutical Industries Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eva Pharmaceutical Industries Branded Generics Product
Table 68. Eva Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 69. Pfizer Business Overview
Table 70. Pfizer Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Pfizer Branded Generics Product
Table 72. Pfizer Response to COVID-19 and Related Developments
Table 73. Sun Pharmaceutical Industries Business Overview
Table 74. Sun Pharmaceutical Industries Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Sun Pharmaceutical Industries Branded Generics Product
Table 76. Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 77. Aspen Pharmacare Holding Business Overview
Table 78. Aspen Pharmacare Holding Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Aspen Pharmacare Holding Branded Generics Product
Table 80. Aspen Pharmacare Holding Response to COVID-19 and Related Developments
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Abbott Laboratories Branded Generics Product
Table 84. Abbott Laboratories Response to COVID-19 and Related Developments
Table 85. Bausch Health Business Overview
Table 86. Bausch Health Branded Generics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bausch Health Branded Generics Product
Table 88. Bausch Health Response to COVID-19 and Related Developments
Table 89. Branded Generics Distributors List
Table 90. Branded Generics Customers List
Table 91. Covid-19 Impact on Branded Generics Customers
LIST OF FIGURES
Figure 1. Branded Generics Product Picture
Figure 2. Branded Generics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Branded Generics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Branded Generics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Branded Generics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Branded Generics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Branded Generics Market Size Market Share, 2019-2021
Figure 1. Branded Generics Product Picture
Figure 2. Branded Generics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Branded Generics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Branded Generics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Branded Generics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Branded Generics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Branded Generics Market Size Market Share, 2019-2021
